Literature DB >> 25315926

Searching for an optimal AUC estimation method: a never-ending task?

Wojciech Jawień1.   

Abstract

An effective method of construction of a linear estimator of AUC in the finite interval, optimal in the minimax sense, is developed and demonstrated for five PK models. The models may be given as an explicit C(t) relationship or defined by differential equations. For high variability and rich sampling the optimal method is only moderately advantageous over optimal trapezoid or standard numerical approaches (Gauss-Legendre or Clenshaw-Curtis quadratures). The difference between the optimal estimator and other methods becomes more pronounced with a decrease in sample size or decrease in the variability. The described estimation method may appear useful in development of limited-sampling strategies for AUC determination, as an alternative to the widely used regression-based approach. It is indicated that many alternative approaches are also possible.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25315926      PMCID: PMC4225057          DOI: 10.1007/s10928-014-9392-y

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  13 in total

1.  Variability of the model-independent AUC: the one sample per individual case.

Authors:  W Jawień
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

2.  Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC).

Authors:  R D Purves
Journal:  J Pharmacokinet Biopharm       Date:  1992-06

3.  Development of limited sampling strategies for characteristics of a pharmacokinetic profile.

Authors:  W M Sallas
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

4.  The variance of a better AUC estimator for sparse, destructive sampling in toxicokinetics.

Authors:  J R Nedelman; E Gibiansky
Journal:  J Pharm Sci       Date:  1996-08       Impact factor: 3.534

5.  Evaluation of limited sampling models for prediction of oral midazolam AUC for CYP3A phenotyping and drug interaction studies.

Authors:  Silke C Mueller; Bernd Drewelow
Journal:  Eur J Clin Pharmacol       Date:  2012-11-07       Impact factor: 2.953

6.  Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.

Authors:  Abraham J Wilhelm; Peer de Graaf; Agnes I Veldkamp; Jeroen J W M Janssen; Peter C Huijgens; Eleonora L Swart
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

7.  Experimental design for estimating integrals by numerical quadrature, with applications to pharmacokinetic studies.

Authors:  D Katz; D Z D'Argenio
Journal:  Biometrics       Date:  1983-09       Impact factor: 2.571

8.  LAGRAN program for area and moments in pharmacokinetic analysis.

Authors:  M L Rocci; W J Jusko
Journal:  Comput Programs Biomed       Date:  1983-06

9.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

10.  Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.

Authors:  Cathryn Sibbald; Winnie Seto; Tracey Taylor; E Fred Saunders; John Doyle; L Lee Dupuis
Journal:  Ther Drug Monit       Date:  2008-08       Impact factor: 3.681

View more
  5 in total

1.  Methods for comparing durability of immune responses between vaccine regimens in early-phase trials.

Authors:  Ted Westling; Michal Juraska; Kelly E Seaton; Georgia D Tomaras; Peter B Gilbert; Holly Janes
Journal:  Stat Methods Med Res       Date:  2019-01-09       Impact factor: 3.021

2.  A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer.

Authors:  Girish S Kulkarni; Lothar Lilge; Michael Nesbitt; Roger J Dumoulin-White; Arkady Mandel; Michael A S Jewett
Journal:  Eur Urol Open Sci       Date:  2022-06-01

3.  GFAp and tau protein as predictors of neurological outcome after out-of-hospital cardiac arrest: A post hoc analysis of the COMACARE trial.

Authors:  Jaana Humaloja; Marika Lähde; Nicholas J Ashton; Matti Reinikainen; Johanna Hästbacka; Pekka Jakkula; Hans Friberg; Tobias Cronberg; Ville Pettilä; Kaj Blennow; Henrik Zetterberg; Markus B Skrifvars
Journal:  Resuscitation       Date:  2021-12-01       Impact factor: 5.262

4.  The Acute Effects of Single or Repeated Bouts of Vigorous-Intensity Exercise on Insulin and Glucose Metabolism during Postprandial Sedentary Behavior.

Authors:  Tobias Engeroff; Eszter Füzeki; Lutz Vogt; Winfried Banzer
Journal:  Int J Environ Res Public Health       Date:  2022-04-07       Impact factor: 4.614

5.  Uncoupling protein 1-independent effects of eicosapentaenoic acid in brown adipose tissue of diet-induced obese female mice.

Authors:  Emily K Miller; Mandana Pahlavani; Latha Ramalingam; Shane Scoggin; Naima Moustaid-Moussa
Journal:  J Nutr Biochem       Date:  2021-07-13       Impact factor: 6.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.